Search Results - "CHANNER, K"

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes by Kapoor, D, Goodwin, E, Channer, K S, Jones, T H

“…Objective: Low levels of testosterone in men have been shown to be associated with type 2 diabetes, visceral adiposity, dyslipidaemia and metabolic syndrome…”
Get full text

Androgens, insulin resistance and vascular disease in men by Kapoor, D., Malkin, C. J., Channer, K. S., Jones, T. H.

“…Summary Type 2 diabetes mellitus is increasing globally and is an established risk factor for the development of atherosclerotic vascular disease. Insulin…”
Get full text

A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO) by Rash, Amar, Downes, Tom, Portner, Robin, Yeo, Wilf W., Morgan, Nicolette, Channer, Kevin S.

“…Background: atrial fibrillation (AF) is the commonest chronic arrhythmia with a prevalence of 9% in octogenarians and accounts for 24% of the stroke risk in…”
Get full text

Poverty and suicide research in low- and middle-income countries: systematic mapping of literature published in English and a proposed research agenda by Bantjes, J., Iemmi, V., Coast, E., Channer, K., Leone, T., McDaid, D., Palfreyman, A., Stephens, B., Lund, C.

“…Approximately 75% of suicides occur in low- and middle-income countries (LMICs) where rates of poverty are high. Evidence suggests a relationship between…”
Get full text

Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life by Malkin, C J, Pugh, P J, Morris, P D, Kerry, K E, Jones, R D, Jones, T H, Channer, K S

“…Background: Low serum testosterone is associated with several cardiovascular risk factors including dyslipidaemia, adverse clotting profiles, obesity, and…”
Get full text

Testosterone treatment for men with chronic heart failure by Pugh, P J, Jones, R D, West, J N, Jones, T H, Channer, K S

“…[...]testosterone has been shown to augment cardiac output acutely in men with CHF. 1, 2 Low plasma concentrations of testosterone have been described in men…”
Get full text

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes by Kapoor, D, Clarke, S, Stanworth, R, Channer, K S, Jones, T H

“…Objective: Serum testosterone levels are known to inversely correlate with insulin sensitivity and obesity in men. Furthermore, there is evidence to suggest…”
Get full text

Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes by Stanworth, R D, Kapoor, D, Channer, K S, Jones, T H

“…ObjectiveTo determine the relationships between androgen receptor CAG repeat polymorphism length (AR CAG), sex hormones and clinical variables in men with type…”
Get full text

Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes by Stanworth, R. D., Kapoor, D., Channer, K. S., Jones, T. H.

“…Summary Objective  There is a high prevalence of low testosterone and dyslipidaemia in men with type 2 diabetes. The androgen receptor CAG repeat polymorphism…”
Get full text

The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study by Stanworth, R D, Akhtar, S, Channer, K S, Jones, T H

“…ContextThe TIMES2 (testosterone replacement in hypogonadal men with either metabolic syndrome or type 2 diabetes) study reported beneficial effects of…”
Get full text

Selective Inhibition of L-Type Ca2+ Channels in A7r5 Cells by Physiological Levels of Testosterone by Hall, J, Jones, R. D, Jones, T. H, Channer, K. S, Peers, C

“…Testosterone has marked beneficial cardiovascular effects, many of which have been attributed to a vasodilatory action. However, the molecular target of…”
Get full text

Chronic atrial fibrillation: a systematic review of medical heart rate control management by Nikolaidou, T, Channer, K S

“…Objective:Recent guidelines by the National Institute for Health and Clinical Excellence (NICE) and the American College of Cardiology/American Heart…”
Get full text

The triad of erectile dysfunction, hypogonadism and the metabolic syndrome by Shabsigh, R, Arver, S, Channer, K S, Eardley, I, Fabbri, A, Gooren, L, Heufelder, A, Jones, H, Meryn, S, Zitzmann, M

“…To identify the relationship of erectile dysfunction, hypogonadism and the metabolic syndrome in the context of men's health. An Expert Panel Meeting was held…”
Get more information

Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability by Malkin, CJ, Pugh, PJ, Jones, RD, Jones, TH, Channer, KS

“…Inflammation plays a central pathogenic role in the initiation and progression of coronary atheroma and its clinical consequences. Cytokines are the mediators…”
Get full text

An evaluation of the effects of Tai Chi Chuan and Chi Kung training in patients with symptomatic heart failure: a randomised controlled pilot study by Barrow, D E, Bedford, A, Ives, G, OToole, L, Channer, K S

“…Objective: To study the effect of Tai Chi on exercise tolerance in patients with moderate heart failure. Design: Randomised parallel group study balanced for…”
Get full text

Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms by English, K.M, Mandour, O, Steeds, R.P, Diver, M.J, Jones, T.H, Channer, K.S

“…Aims High androgen levels are presumed by many to explain the male predisposition to coronary artery disease. However, natural androgens inhibit male…”
Get full text

Testosterone and coronary artery disease by Nettleship, J, Jones, R, Channer, K, Jones, T

“…The strongest independent risk factors for coronary artery disease (CAD) are increasing age and male gender. Whilst a wide variation in CAD mortality exists…”
Get more information

Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction by CROFT, S. A, SAMANI, N. J, TEARE, M. D, HAMPTON, K. K, STEEDS, R. P, CHANNER, K. S, DALY, M. E

“…Glycoprotein (GP) VI plays a crucial role in platelet activation and aggregation. We investigated whether polymorphic variation at the GP VI locus confers an…”
Get full text

Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes by Kapoor, D., Clarke, S., Channer, K. S., Jones, T. H.

“…Summary Low testosterone levels in men are associated with type 2 diabetes mellitus. Erectile dysfunction (ED) is a frequent complication of type 2 diabetes…”
Get full text

Testosterone acts as a coronary vasodilator by a calcium antagonistic action by ENGLISH, K. M, JONES, R. D, JONES, T. H, MORICE, A. H, CHANNER, K. S

“…T acts as a vasodilator in vitro and in vivo. Supplemental T therapy in humans with angina improves symptoms and reduces objective measures of ischemia. In…”
Get full text